Non-traditional risk factors for coronary calcification and its progression in patients with type 2 diabetes: The impact of postprandial glycemia and fetuin-A.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Sage Publications Country of Publication: England NLM ID: 0346411 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-2300 (Electronic) Linking ISSN: 03000605 NLM ISO Abbreviation: J Int Med Res Subsets: MEDLINE
    • Publication Information:
      Publication: Nov. 2012- : London : Sage Publications
      Original Publication: Northampton, Eng., Cambridge Medical Publications ltd.
    • Subject Terms:
    • Abstract:
      Objective: This study was performed to assess the impact of risk factors on the presence and progression of coronary calcification in patients with type 2 diabetes.
      Methods: We prospectively enrolled 45 patients without cardiovascular or kidney disease. Coronary calcification was measured with multidetector computed tomography at baseline and 18 months. We also measured blood pressure; body mass index; serum levels of calcium, phosphate, and 25-hydroxyvitamin D; mineral bone density; and levels of alkaline phosphatase, parathormone, fetuin-A, high-sensitivity C-reactive protein, fibrinogen, albumin, homocysteine, lipids, HbA1c, and average preprandial and postprandial blood glucose at 18 months. Information about severe hypoglycemia and smoking was recorded. Spearman's correlation coefficients were calculated. Multiple linear regression was used for the multivariate analysis.
      Results: The median baseline calcium score was 63, and that at 18 months was 100. In the univariate analysis, albumin was significantly correlated with the baseline calcium score. Fetuin-A and postprandial glycemia were correlated with calcium score progression. In the multivariate model, postprandial glycemia and fetuin-A were independently associated with calcium score progression.
      Conclusions: Fetuin-A and postprandial glycemia influence coronary calcification progression in patients with type 2 diabetes. The absence of some correlations could be due to pharmacological treatments for cardiovascular risk reduction.
    • References:
      Circulation. 2000 Apr 4;101(13):1506-11. (PMID: 10747342)
      J Clin Endocrinol Metab. 2001 Jan;86(1):32-8. (PMID: 11231974)
      Nutrition. 2002 Feb;18(2):199-200. (PMID: 11844655)
      Diabetes Care. 2004 Apr;27(4):889-94. (PMID: 15047644)
      Kidney Int Suppl. 2004 Nov;(92):S50-5. (PMID: 15485418)
      Arch Intern Med. 2005 Jul 25;165(14):1612-7. (PMID: 16043679)
      Eur Heart J. 2006 Apr;27(8):905-12. (PMID: 16087647)
      J Clin Endocrinol Metab. 2006 Mar;91(3):813-9. (PMID: 16352690)
      Circulation. 2006 Oct 17;114(16):1761-91. (PMID: 17015792)
      Diabet Med. 2006 Nov;23(11):1192-200. (PMID: 17054594)
      Atherosclerosis. 2008 Apr;197(2):777-83. (PMID: 17920067)
      J Am Coll Cardiol. 2007 Dec 4;50(23):2218-25. (PMID: 18061069)
      Diabetologia. 2008 Mar;51(3):493-501. (PMID: 18183363)
      Vasc Health Risk Manag. 2008;4(2):315-24. (PMID: 18561507)
      Atherosclerosis. 2008 Nov;201(1):1-7. (PMID: 18561934)
      Eur Radiol. 2008 Dec;18(12):2785-807. (PMID: 18651153)
      Ann Epidemiol. 2008 Nov;18(11):847-50. (PMID: 18809342)
      Curr Opin Clin Nutr Metab Care. 2008 Nov;11(6):752-7. (PMID: 18827580)
      BMC Cardiovasc Disord. 2008 Oct 10;8:27. (PMID: 18847481)
      Atherosclerosis. 2009 Jul;205(1):255-60. (PMID: 19091317)
      Diabetes Care. 2009 Mar;32(3):381-6. (PMID: 19246588)
      Am J Med. 2009 Apr;122(4):380-6. (PMID: 19332233)
      Cardiovasc Diabetol. 2009 Apr 29;8:23. (PMID: 19402896)
      J Am Soc Nephrol. 2009 Aug;20(8):1805-12. (PMID: 19443637)
      JACC Cardiovasc Imaging. 2009 Jun;2(6):675-88. (PMID: 19520336)
      Atherosclerosis. 2010 Mar;209(1):226-9. (PMID: 19766217)
      Nat Rev Cardiol. 2009 Nov;6(11):681-8. (PMID: 19786983)
      Atherosclerosis. 2010 Jun;210(2):331-6. (PMID: 19969300)
      Metabolism. 2010 Jun;59(6):873-8. (PMID: 20015522)
      Atherosclerosis. 2010 Jun;210(2):671-3. (PMID: 20079495)
      Diabetes Care. 2010 Jun;33(6):1236-8. (PMID: 20215453)
      Diabetes Care. 2010 Oct;33(10):2238-43. (PMID: 20606205)
      N Engl J Med. 2010 Oct 7;363(15):1410-8. (PMID: 20925543)
      J Am Coll Cardiol. 2010 Nov 9;56(20):1613-22. (PMID: 21050970)
      Cardiovasc Diabetol. 2011 Feb 25;10:19. (PMID: 21349201)
      Rev Diabet Stud. 2010 Fall;7(3):188-201. (PMID: 21409311)
      Diabetes Care. 2012 Jan;35(1):168-72. (PMID: 22040839)
      J Diabetes Complications. 2011 Nov-Dec;25(6):355-61. (PMID: 22055259)
      J Clin Densitom. 2012 Jan-Mar;15(1):55-60. (PMID: 22071025)
      J Am Coll Cardiol. 2011 Nov 29;58(23):2372-9. (PMID: 22115642)
      Cardiovasc Diabetol. 2011 Dec 22;10:116. (PMID: 22192330)
      Diabetes Care. 2012 Feb;35(2):396-403. (PMID: 22210562)
      J Clin Endocrinol Metab. 2012 Apr;97(4):1277-84. (PMID: 22337915)
      Curr Diabetes Rev. 2012 Jan;8(1):42-7. (PMID: 22414057)
      Eur Heart J. 2012 May;33(10):1201-13. (PMID: 22547221)
      J Am Coll Cardiol. 2012 May 8;59(19):1688-96. (PMID: 22554599)
      BMJ Open. 2012 Nov 30;2(6):null. (PMID: 23204139)
      Am J Cardiol. 2013 Feb 1;111(3):356-61. (PMID: 23206921)
      Diabetes Care. 2013 May;36(5):1222-8. (PMID: 23250801)
      Diabetologia. 2013 Apr;56(4):686-95. (PMID: 23354123)
      Arterioscler Thromb Vasc Biol. 2013 May;33(5):1070-6. (PMID: 23430618)
      BMJ. 2013 Mar 25;346:f1654. (PMID: 23529983)
      BMJ. 2013 Jul 29;347:f4533. (PMID: 23900314)
      Blood Press. 2014 Feb;23(1):3-16. (PMID: 24359485)
      Clin Biochem. 2014 May;47(7-8):670-2. (PMID: 24525255)
      Diabetes Care. 2016 Mar;39(3):448-54. (PMID: 26786575)
      Lancet Diabetes Endocrinol. 2017 Nov;5(11):877-886. (PMID: 28917545)
      Arterioscler Thromb Vasc Biol. 1998 Jan;18(1):133-8. (PMID: 9445267)
    • Contributed Indexing:
      Keywords: (non-traditional/new) risk factors; Diabetes mellitus; coronary calcification; fetuin-A; hyperglycemia; postprandial; type 2
    • Accession Number:
      0 (AHSG protein, human)
      0 (Biomarkers)
      0 (Blood Glucose)
      0 (alpha-2-HS-Glycoprotein)
    • Publication Date:
      Date Created: 20190109 Date Completed: 20190611 Latest Revision: 20200225
    • Publication Date:
      20221213
    • Accession Number:
      PMC6381483
    • Accession Number:
      10.1177/0300060518814080
    • Accession Number:
      30616461